ReviewJournal of pharmaceutical sciences2026

Classification system proposed to guide the design, development, regulatory approval, and scaling of long acting, small- and macro-molecule parenteral products (CS-BLAP).

Simone Perazzolo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.